HealthMap Solutions Files IPO Prospectus Following $100M Funding and Serving Over 160,000 Kidney Disease Patients

“The five zang organs are the foundation of the human body, and the kidney is the foundation of the five zang organs.” In Traditional Chinese Medicine (TCM), the kidney is metaphorically referred to as the “congenital foundation.” As the body’s “filter,” the kidney plays a pivotal role in urine production and excretion of metabolic waste, maintaining fluid balance and acid-base homeostasis, and secreting hormone-like bioactive substances. However, approximately one-tenth of the global population suffers from kidney disease.

Data released by the Chinese Society of Nephrology indicates that there are currently approximately 850 million people worldwide living with chronic kidney disease (CKD). Relevant statistics show that the global prevalence of CKD ranges from 10.1% to 13.3%, exceeding that of diabetes, chronic obstructive pulmonary disease, and depression. It is projected that by 2040, CKD will become the fifth leading cause of death globally. As early as 2020, the World Health Organization’s Global Health Estimates 2019 report revealed that kidney diseases had already ranked among the top ten causes of death worldwide.

Treating kidney disease is challenging, partly due to the diverse causes, complex pathogenesis, and high tendency for recurrence of renal disorders, and partly because overlapping symptoms and complications necessitate more comprehensive and meticulous management, thereby complicating medication regimens. The difficulty in treatment and the propensity for relapse mean that the course of therapy for kidney disease is often prolonged, with some patients requiring long-term or even lifelong treatment. Healthmap Solutions’ Kidney Health Management (KHM) program provides comprehensive, long-term healthcare and treatment for patients with kidney disease.

HealthMap Solutions is an NCQA-certified health management company for kidney disease patients, established by a team comprising health plans, specialized healthcare providers, population health experts, technology and data analytics specialists, and clinical professionals. It is dedicated to providing efficient, high-quality care solutions for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The KHM model emphasizes early detection and identification, slowing disease progression, and planned care transitions. It collaborates with healthcare institutions and patients to proactively plan care transitions and optimize renal replacement therapy strategies, focusing on early CKD identification and intervention, timely referral to nephrology specialists, advanced renal replacement planning, and patient-centered comprehensive care management. Healthmap Solutions is results-oriented, with all actions aimed at achieving expected, measurable outcomes. If these goals are not met, Healthmap Solutions will adjust its approach to continuously improve its services.

Healthmap Solutions collaborates directly with healthcare institutions to identify patients who have not yet been diagnosed by nephrologists, facilitating critical referrals to ensure that those with advanced chronic kidney disease (CKD) receive timely specialist evaluation and avoid missing the optimal window for treatment.

Furthermore, Healthmap Solutions’ patented, NCQA pre-validated technology platform leverages data analytics to identify patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), stratifying them by risk according to CKD stage to ensure timely treatment and care. Early interventions are then implemented based on clinically proven, personalized health action plans to slow disease progression. Throughout this process, Healthmap Solutions ensures equity, guaranteeing that all members—regardless of race, gender, socioeconomic background, geographic location, or insurance type—receive guideline-recommended care, particularly for those referred to nephrology specialists.

Healthmap Solutions adheres to a patient-centered care model, in which its multidisciplinary care navigation team communicates directly with patients to help them understand their conditions, fully engage in the care and treatment process, and adhere to their treatment plans. This approach enables Healthmap Solutions to provide tailored care plans based on various factors, including resource and education availability, medication assessment, and dietary review.

Healthmap Solutions provides personalized dialysis care plans, developing tailored programs for patients preparing to receive dialysis services to meet their unique needs, including the determination of service location, modality, and schedule. By maintaining regular communication with healthcare institutions and clinical teams, Healthmap Solutions delivers collaborative patient care to identify disease risks, analyze and bridge existing gaps in care, plan care transitions, and avoid unnecessary treatments.

During treatment, financial hardships related to transportation, meals, housing, medication costs, or healthcare often pose significant barriers to patient adherence. The team of social workers, dietitians, and pharmacists at Healthmap Solutions collaborates with local communities to connect patients with community service resources and help alleviate their financial burden through its capabilities in addressing the social determinants of health.

Healthmap Solutions also recognizes that patients with advanced chronic kidney disease (CKD) are susceptible to behavioral health issues such as anxiety and depression. Therefore, all members of the Kidney Health Management (KHM) program who interact with care navigators undergo screening for these conditions. When issues are identified, the team assists patients in obtaining referrals to behavioral health professionals to prevent these conditions from compromising the effectiveness of their care.

Healthmap Solutions has extensive experience in data scraping and analysis, providing healthcare institutions with up-to-date data and clinically validated care recommendations. This delivers data-driven support for care planning, enabling these institutions to make optimal care decisions for their patients.

Meanwhile, Healthmap Solutions’ Compass platform, corporate network domain, and workstations are all HITRUST CSF-certified.^®Certification enables risk management, improves security posture, and ensures compliance with HITRUST requirements. The company strictly adheres to relevant federal and state laws and regulations during data collection and analysis, ensuring that patients’ Protected Health Information (PHI) and Personally Identifiable Information (PII) are used solely for authorized purposes, such as delivering health services, conducting research, and developing care plans. When engaging with the KHM program, patients have the right to determine the confidentiality of their medical and personal information, understand who has access to their data, and learn how Healthmap Solutions safeguards their information security.

In 2022, more than 130,000 Americans developed end-stage renal disease (ESRD). Most patients undergo dialysis three times a week at dialysis centers, with only 15% opting for home-based dialysis.

Home dialysis offers many significant advantages over in-center hemodialysis (HD), such as greater flexibility in dialysis scheduling, reduced post-treatment fatigue, fewer dietary and fluid restrictions, and a higher likelihood of kidney transplantation. Despite these benefits, home dialysis remains an elusive luxury for racial and ethnic minorities and individuals with lower socioeconomic status—groups that have historically demonstrated the lowest utilization rates of home dialysis. This disparity stems from systemic neglect of the various health inequities faced by these populations. Healthmap Solutions is committed to increasing home dialysis utilization among all its Kidney Health Management (KHM) program members in an equitable manner.

Previous studies have found that among patients receiving in-center hemodialysis, one-third to two-thirds reported not recalling receiving education on home dialysis or stated that the decision to undergo in-center hemodialysis was not made by themselves. Targeted pre-dialysis education has been shown to increase the rate of home dialysis by nearly fourfold. Therefore, Healthmap Solutions delivers pre-dialysis education through a "shared decision-making" approach.

Merely distributing brochures on home dialysis is unlikely to achieve the desired outcomes. In contrast, general education on topics such as dialysis modality selection is most likely to succeed when delivered through a shared decision-making approach. Healthmap Solutions provides patients with evidence-based treatment options, emphasizing an understanding of the risks and benefits of their chosen therapy compared with reasonable alternatives, thereby enabling them to select the treatment plan best suited to their needs.

Building a strong relationship with patients is a crucial component in ensuring optimal care outcomes. Under the KHM model, patients have the right to be informed of all treatment options and to engage in shared decision-making with their physicians. Healthmap Solutions also reviews patients’ medical histories and medication regimens, collaborates with them to complete health risk assessments, and educates them on how to manage their health conditions, adhere to medication schedules, maintain proper nutrition, and understand and follow medical instructions.

The goal of the KHM program is to optimize renal replacement therapy (RRT) for patients with end-stage renal disease (ESRD), enabling them to receive better kidney disease education and access RRT options, regardless of whether they are undergoing dialysis or have initiated kidney transplant evaluation. Although the KHM program supports both dialysis and kidney transplantation, kidney transplantation is the preferred long-term option when clinically appropriate for the patient. Compared with dialysis, kidney transplant recipients are more likely to resume a normal lifestyle, face fewer dietary restrictions, and experience improved overall health. For example, compared with dialysis, kidney transplantation helps control hypertension and reduces the risk of cardiovascular disease.

Therefore, in addition to assessing patients’ eligibility for dialysis, Healthmap Solutions also identifies suitable candidates for kidney transplantation and provides the comprehensive care and follow-up necessary for successful transplant outcomes. Care navigation nurses at Healthmap Solutions communicate directly with patients to help them understand kidney transplantation, identify social barriers to care, and ensure that these factors do not hinder their participation in the transplant evaluation process. If patients and their care teams determine that transplantation is the right choice, Healthmap Solutions will assist them in getting listed for a kidney transplant.

Meanwhile, if members opt for dialysis treatment, Healthmap Solutions will continue to collaborate with them to ensure a seamless transition to end-stage renal disease (ESRD) care. Care navigators will continue to provide support, helping patients communicate with healthcare facilities, undergo surgical placement of dialysis access, and receive ongoing education on topics such as transplant evaluation as needed. By reducing the rate of unplanned dialysis initiation by 65%, Healthmap Solutions has effectively improved patient outcomes while lowering hospitalization rates and avoidable medical costs.

In February 2023, NCQA selected Healthmap Solutions as part of its “Chronic Kidney Disease Population Health Roadmap.” Additionally, Healthmap Solutions’ Kidney Health Management (KHM) program has been recognized by the National Kidney Foundation of Florida.

On August 1, 2023, Healthmap Solutions announced the completion of a $100 million private equity financing round to support its continued business expansion. The round was led by WindRose Health Investors, a firm focused on private equity investments in companies within the healthcare services industry. Healthmap Solutions has experienced rapid growth in its health plan client base and is currently contracted to provide services to more than 160,000 patients with kidney disease. Today, Healthmap Solutions has established partnerships with many leading health plan providers in the United States, managing over $3 billion in healthcare expenditures.

References:

United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022.